Effects of interferon beta-1b +/- atorvastatin on cerebral atrophy in patients with relapsing-remitting multiple sclerosis

Trial Profile

Effects of interferon beta-1b +/- atorvastatin on cerebral atrophy in patients with relapsing-remitting multiple sclerosis

Completed
Phase of Trial: Phase II

Latest Information Update: 08 Nov 2012

At a glance

  • Drugs Atorvastatin (Primary) ; Interferon beta-1b
  • Indications Multiple sclerosis
  • Focus Therapeutic Use
  • Acronyms ARIANNA
  • Most Recent Events

    • 08 Nov 2012 New trial record
    • 13 Oct 2012 Results presented at the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top